Discontinued — last reported Q2 '25
Danaher Intangible Amortization increased by 1.4% to $434.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $410.00M to $434.00M. Over 4 years (FY 2021 to FY 2025), Intangible Amortization shows an upward trend with a 5.2% CAGR.
An increase often follows a period of aggressive M&A activity, reflecting the cost of integrating acquired intellectual property.
This metric tracks the systematic write-down of the value of acquired intangible assets, such as patents, trademarks, an...
Common in companies with high M&A activity; peers in the medical device sector typically show consistent levels.
amortization_of_intangibles| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $347.00M | $365.00M | $332.00M | $386.00M | $373.00M | $361.00M | $314.00M | $372.00M | $372.00M | $367.00M | $380.00M | $407.00M | $402.00M | $414.00M | $408.00M | $410.00M | $426.00M | $433.00M | $428.00M | $434.00M |
| QoQ Change | — | +5.2% | -9.0% | +16.3% | -3.4% | -3.2% | -13.0% | +18.5% | +0.0% | -1.3% | +3.5% | +7.1% | -1.2% | +3.0% | -1.4% | +0.5% | +3.9% | +1.6% | -1.2% | +1.4% |
| YoY Change | — | — | — | — | +7.5% | -1.1% | -5.4% | -3.6% | -0.3% | +1.7% | +21.0% | +9.4% | +8.1% | +12.8% | +7.4% | +0.7% | +6.0% | +4.6% | +4.9% | +5.9% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Biotechnology | $213.00M | $228.00M | $231.00M | — | $234.00M |
| Life Sciences | $149.00M | — | — | $151.00M | $152.00M |
| Diagnostics | $48.00M | — | — | $47.00M | $48.00M |
| Total | $410.00M | $426.00M | $433.00M | $428.00M | $434.00M |